Skip to main content

Applied Therapeutics, Inc.

APLTDelisted Feb 3, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001697532

Applied Therapeutics, Inc. was delisted on Feb 3, 2026; its insiders filed their last Form 4 on Feb 4, 2026; 52 institutions reported holding it in 13F filings for Q4 2025, worth $5.93M in total; no superinvestor held it.

Q2 2022 vs. Q1 2022

How the institutions holding Applied Therapeutics, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of APLT: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders71253−16
Shares12.4M29.8K26.7M+14.4M (+117.0%)
Value$26.0M$63.0K$25.3M−$657.5K (−2.5%)

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (10)

Institutions that held Applied Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to APLT in Q2 2022
InstitutionSharesValue% of portfolio
Alyeska Investment Group, L.P.4,357,690$4.13M0.05%
OrbiMed Advisors LLC4,250,000$4.03M0.08%
Empery Asset Management, LP675,000$640.0K3.47%
Laurion Capital Management LP345,900$328.0K0.01%
Ergoteles LLC86,600$82.0K0.00%
Maven Securities LTD50,000$47.0K0.01%
Qube Research & Technologies Ltd17,370$16.0K0.00%
Susquehanna International Group, LLP13,076$12.0K0.00%
Allworth Financial LP250$00.00%
Mirae Asset Global Investments Co., Ltd.30,669––

Sold out (26)

Institutions that held Applied Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Not filed for Q2 2022 yet (2)

Institutions that held Applied Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding APLT in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Parametric Portfolio Associates LLC26,981$57.0K
Amalgamated Financial Corp.2,828$6.00K